Safest Opioids for Patients with Cirrhosis

First-line Opioid Options

Fentanyl is the preferred opioid option for patients with cirrhosis due to its stable blood concentration and lack of toxic metabolites, as recommended by the American Association for the Study of Liver Diseases 1, 2, 3
Hydromorphone has an analgesic effect with a stable half-life in patients with liver dysfunction, but requires dose reduction with standard intervals, according to the European Association for the Study of the Liver 2, 4
Morphine can be used but requires significant dosage adjustment, with a two-fold increase in half-life and four-fold increase in bioavailability in patients with hepatocellular carcinoma, as reported by the American College of Gastroenterology 1, 3, 4

Codeine should be avoided in patients with liver cirrhosis due to the risk of metabolite accumulation and side effects such as respiratory depression, as warned by the European Association for the Study of the Liver 1, 5
Oxycodone has a longer half-life, lower clearance, and greater potency for respiratory depression in cirrhotic patients, and is recommended to be avoided by the European Association for the Study of the Liver 2, 3
Tramadol bioavailability may increase two to three-fold in patients with liver cirrhosis, and should be administered with caution, with a maximum dose of 50 mg within 12 hours, as advised by the American Association for the Study of Liver Diseases 5, 6

The American Association for the Study of Liver Diseases recommends starting with lower doses and increasing slowly, due to the risk of adverse effects in patients with liver disease 3, 4
Extended dosing intervals are recommended for most opioids, especially morphine, with a 1.5-2 times increase in the normal interval, as suggested by the European Association for the Study of the Liver 4, 7
Close monitoring is essential for signs of sedation, respiratory depression, and hepatic encephalopathy, particularly when initiating therapy and at each dosage increase, as emphasized by the American College of Gastroenterology 2

Opioids can increase the risk of hepatic encephalopathy in patients with liver dysfunction, and should be used with caution, as warned by the European Association for the Study of the Liver 2, 3
The severity of liver disease should guide the approach to opioid selection and dosing, with more severe disease requiring a more cautious approach, as recommended by the American Association for the Study of Liver Diseases 3
NSAIDs should be avoided due to the risk of side effects such as nephrotoxicity, gastric ulcers, and decompensation in patients with liver cirrhosis, as advised by the European Association for the Study of the Liver 5, 8
Acetaminophen should be used at reduced doses in patients with liver disease, due to the risk of hepatotoxicity, as recommended by the American Association for the Study of Liver Diseases 5, 8

Renal function should be assessed in cirrhotic patients, as many opioid metabolites are excreted by the kidneys and may accumulate in patients with concurrent renal insufficiency, as emphasized by the European Association for the Study of the Liver 9